Viral use and mimicry of autophagy pathway and components
Viral use and mimicry of autophagy pathway and components
批准号:
9757678
负责人:
Karla Kirkegaard
金额:
$38.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-10 至 2022-07-31
关键词:
Animal ModelAntiviral AgentsAutophagocytosisAutophagosomeBacteriaBindingBirdsCRISPR/Cas technologyCell LineCell physiologyCellsCellular MembraneChimeric ProteinsCommunicable DiseasesComplexCoxsackie VirusesCytoplasmDataDefectDengueDengue InfectionDengue VirusDependenceDevelopmentDiseaseEatingEnterovirusEnterovirus 71EventFastingFlavivirusFosteringGene DeletionGene ProteinsGenesGeneticGenetic screening methodGoalsGrowthHealthHepatitis CHumanHuman poliovirusIndividualInfectionInnate Immune ResponseKnowledgeLaboratoriesLipidsLysosomesMalignant NeoplasmsMeasuresMediatingMembraneMicrobeMissionModelingMorphogenesisMorphologyNobel PrizeNonlyticOutcomeOutcomes ResearchParasitesPathogenesisPathway interactionsPharmaceutical PreparationsPositioning AttributeProcessProductionProteomicsPublic HealthPublishingRNA Virus InfectionsRNA VirusesRNA replicationRecommendationRecyclingResearchRoleSolid NeoplasmSurfaceTestingTranslationsUnited States National Institutes of HealthViralVirionVirusVirus DiseasesVirus ReplicationWorkZika Virusbaseburden of illnessexperimental studyhuman diseaseinhibitor/antagonistinsightmimicrymouse modelnovelnutrient deprivationparticlepreventresponsetoolviral RNA
中文摘要
这项工作的长期目标是确定
自噬途径促进病毒复制和传播,并确定发展的目标
无毒的抗病毒化合物。典型的自噬(自噬)途径,由
最近的诺贝尔奖获得者大滨义典被营养剥夺刺激并达到顶峰
在细胞质内容物的降解,从而滋养饥饿的细胞。为此,
戏剧性的细胞事件,如大量的脂质清除,新的细胞膜的生长
隔室,通过凹面和凸面膜曲率对细胞质的包裹;
与溶酶体的融合在几分钟内完成。大量的微生物,包括
脊髓灰质炎病毒和登革热病毒,已经进化到颠覆细胞自噬的片段
途径或其单个成分,以促进其感染周期。精准的个体
自噬途径中的基因和蛋白质的贡献尚未被确定为
这些病毒。在这里提出的实验中,CRISPR/Cas9技术将被用于
产生匹配的细胞系,用于个别步骤,如自噬启动、扩增
以及限制膜的曲率,以及将关键的融合蛋白LC3放置在
新生自噬小体的表面。测试单个基因缺失对基因突变的影响
脊髓灰质炎病毒和登革热病毒的进入、翻译、RNA复制和形态发生将揭示
自噬途径的哪些组成部分被这两个具有代表性的阳性-
链RNA病毒。
根据初步结果,中心假设是脊髓灰质炎病毒和登革热病毒使用
不同目的的细胞自噬途径的不同步骤和组成部分:RNA
脊髓灰质炎病毒的复制和非裂解传播,登革热病毒的病毒粒子组装和成熟。
拟议研究的基本原理是,一旦这些成分和机制
如果确定了颠覆性事件,则将抗病毒化合物作为特定目标是可行的
分子和过程。毫不奇怪,考虑到这些病毒对自噬的依赖
机制,短期禁食大大加剧了这两种动物模型的发病
脊髓灰质炎病毒和登革热病毒感染。这种恶化也可以观察到作为对
已知的刺激自噬的常用药物。将使用严格的基因测试
为了确定这种增加的发病机制是否真的依赖于细胞自噬
路径。
英文摘要
The long-term goals of this work are to determine the mechanisms by which components of the
autophagy pathway promote viral replication and spread and to identify targets for development
of non-toxic antiviral compounds. The canonical autophagy (self-eating) pathway, described by
recent Nobel Prize winner Yoshinori Ohsumi, is stimulated by nutrient deprivation and culminates
in the degradation of cytoplasmic contents, thus nourishing the starving cell. To this end,
dramatic cellular events such as massive lipid scavenging, growth of novel membranous
compartments, entrapment of cytoplasm by both concave and convex membrane curvature, and
fusion with lysosomes are accomplished within minutes. Numerous microbes, including
poliovirus and Dengue virus, have evolved to subvert segments of the cellular autophagy
pathway or its individual constituents to promote their infectious cycles. The precise individual
contributions of genes and proteins from autophagy pathways have not been identified for any of
these viruses. In the experiments proposed here, CRISPR/Cas9 technology will be used to
generate matched cell lines oblated for individual steps such as autophagy initiation, expansion
and curvature of the limiting membrane, and placement of crucial fusion protein LC3 on the
surface of the nascent autophagosome. Testing the effects of individual gene deletions on the
entry, translation, RNA replication and morphogenesis of poliovirus and dengue virus will reveal
which components of the autophagy pathway are usurped by these two representative positive-
strand RNA viruses.
The central hypothesis, based on preliminary results, is that poliovirus and dengue virus use
distinct steps and components of the cellular autophagy pathway for disparate purposes: RNA
replication and nonlytic spread for poliovirus, virion assembly and maturation for dengue virus.
The rationale of the proposed research is that, once the components and mechanisms of these
subversive events are identified, it will be feasible to target antiviral compounds to particular
molecules and processes. Not surprisingly, given the dependence of these viruses on autophagy
machinery, short periods of fasting greatly exacerbate pathogenesis in mouse models of both
poliovirus and dengue virus infection. This exacerbation is also observed in response to
commonly used medications known to stimulate autophagy. Rigorous genetic tests will be used
to determine whether this increased pathogenesis is indeed dependent on the cellular autophagy
pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Viral use and mimicry of autophagy pathway and components
-
批准号:9975099
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2018
-
负责人:Karla Kirkegaard
-
依托单位:
Viral use and mimicry of autophagy pathway and components
-
批准号:10215472
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2018
-
负责人:Karla Kirkegaard
-
依托单位:
Subversion of Autophagy Pathway and Constituents by RNA viruses
-
批准号:8697258
-
项目类别:
-
资助金额:$46.63万
-
财政年份:2013
-
负责人:Karla Kirkegaard
-
依托单位:
Inhibiting Cellular Autophagy to Thwart Dengue Virus Packaging and Replication
-
批准号:8505375
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2012
-
负责人:Karla Kirkegaard
-
依托单位:
Inhibiting Cellular Autophagy to Thwart Dengue Virus Packaging and Replication
-
批准号:8391666
-
项目类别:
-
资助金额:$23.57万
-
财政年份:2012
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7292758
-
项目类别:
-
资助金额:$78.94万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The cell biology of Theiler's virus persistence in CNS
-
批准号:7244401
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The Cell Biology of Theiler's Virus Persisstence in CNS
-
批准号:7144321
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7195852
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7660318
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The cell biology of Theiler's virus persistence in CNS
-
批准号:7450864
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The Cell Biology of Theiler's Virus Persistence in CNS
-
批准号:7635920
-
项目类别:
-
资助金额:$61.47万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The Cell Biology of Theiler's Virus Persistence in CNS
-
批准号:7880050
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7914217
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6860089
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6632366
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6887625
-
项目类别:
-
资助金额:$6.25万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6232924
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
Viruses And Cells Gordon Conference
-
批准号:6359845
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6511404
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
海外基金